At 22, Emma Operacz found out she had stage 4 T-cell lymphoma. Now, she wants to give back to others facing a similar ...

Financing co-led by new investors, Ascenta Capital and Bessemer Venture PartnersAdditional new investors included YK Bioventures, Regeneron Ventures, Invus, and Finchley Healthcare Ventures, along ...

Citi Annual Global Healthcare Conference 2025 December 3, 2025 9:00 AM ESTCompany ParticipantsDavid Hung - Founder, President, ...

Proceeds collected from the jersey auction and mystery puck sales, as well as the Dallas Stars Foundation 50/50 Raffle will ...

This satellite symposium at the European Society for Medical Oncology (ESMO) Congress 2025, chaired by Rana McKay, Professor ...

Can you get lung cancer without smoking? Yes. A leading oncologist explains the key differences in diagnosis, treatment, and ...

Cancer cells behave differently from normal cells, and some tumours may even use autophagy to survive. That’s why ...

Lung cancer has traditionally been seen as a smoking-related disease, which has led people to believe it's a result of a ...

For those with ALK+ NSCLC who received first-line, next-generation ALK TKI monotherapy, continuing ALK TKI with chemotherapy is linked to better outcomes.

A 46-year-old man with advanced lung cancer recovered after doctors used Next Generation Sequencing to identify a rare ALK fusion mutation and treat him with targeted therapy instead of chemotherapy.

In recent years, traditional surgery, chemotherapy, and radiotherapy alone may fail to acquire satisfactory effects for ...